|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 166 | 20 | 12.0 | 95 | 57.2 | 38 | 22.9 | 11 | 6.6 | 2 | 1.2 |
| 2015-2019 | 160 | 20 | 12.5 | 94 | 58.7 | 35 | 21.9 | 9 | 5.6 | 2 | 1.3 |
| 2014-2018 | 163 | 28 | 17.2 | 85 | 52.1 | 39 | 23.9 | 8 | 4.9 | 3 | 1.8 |
| 2013-2017 | 159 | 33 | 20.8 | 83 | 52.2 | 35 | 22.0 | 5 | 3.1 | 3 | 1.9 |
| 2012-2016 | 155 | 30 | 19.4 | 87 | 56.1 | 31 | 20.0 | 4 | 2.6 | 3 | 1.9 |
| 2011-2015 | 156 | 32 | 20.5 | 86 | 55.1 | 28 | 17.9 | 8 | 5.1 | 2 | 1.3 |
| 2010-2014 | 158 | 32 | 20.3 | 89 | 56.3 | 28 | 17.7 | 7 | 4.4 | 2 | 1.3 |
| 2009-2013 | 152 | 26 | 17.1 | 88 | 57.9 | 27 | 17.8 | 8 | 5.3 | 3 | 2.0 |
| 2008-2012 | 158 | 22 | 13.9 | 95 | 60.1 | 30 | 19.0 | 8 | 5.1 | 3 | 1.9 |
| 2007-2011 | 168 | 27 | 16.1 | 94 | 56.0 | 34 | 20.2 | 9 | 5.4 | 4 | 2.4 |
| 2006-2010 | 172 | 28 | 16.3 | 97 | 56.4 | 36 | 20.9 | 5 | 2.9 | 6 | 3.5 |
| 2005-2009 | 166 | 28 | 16.9 | 86 | 51.8 | 39 | 23.5 | 5 | 3.0 | 8 | 4.8 |
| 2004-2008 | 173 | 30 | 17.3 | 89 | 51.4 | 43 | 24.9 | 4 | 2.3 | 7 | 4.0 |
| 2003-2007 | 166 | 29 | 17.5 | 85 | 51.2 | 42 | 25.3 | 3 | 1.8 | 7 | 4.2 |
| 2002-2006 | 153 | 24 | 15.7 | 80 | 52.3 | 39 | 25.5 | 3 | 2.0 | 7 | 4.6 |
| 2001-2005 | 155 | 22 | 14.2 | 88 | 56.8 | 35 | 22.6 | 3 | 1.9 | 7 | 4.5 |
| 2000-2004 | 163 | 24 | 14.7 | 92 | 56.4 | 36 | 22.1 | 4 | 2.5 | 7 | 4.3 |
| 1999-2003 | 159 | 21 | 13.2 | 91 | 57.2 | 35 | 22.0 | 5 | 3.1 | 7 | 4.4 |
| 1998-2002 | 161 | 24 | 14.9 | 90 | 55.9 | 35 | 21.7 | 5 | 3.1 | 7 | 4.3 |
| 1997-2001 | 165 | 26 | 15.8 | 88 | 53.3 | 34 | 20.6 | 5 | 3.0 | 12 | 7.3 |
| 1996-2000 | 155 | 23 | 14.8 | 81 | 52.3 | 34 | 21.9 | 6 | 3.9 | 11 | 7.1 |
| 1995-1999 | 151 | 20 | 13.2 | 81 | 53.6 | 33 | 21.9 | 6 | 4.0 | 11 | 7.3 |
| 1994-1998 | 152 | 19 | 12.5 | 80 | 52.6 | 36 | 23.7 | 5 | 3.3 | 12 | 7.9 |
| 1993-1997 | 141 | 15 | 10.6 | 70 | 49.6 | 38 | 27.0 | 5 | 3.5 | 13 | 9.2 |
| 1992-1996 | 145 | 17 | 11.7 | 66 | 45.5 | 49 | 33.8 | 3 | 2.1 | 10 | 6.9 |
| 1991-1995 | 149 | 18 | 12.1 | 60 | 40.3 | 53 | 35.6 | 4 | 2.7 | 14 | 9.4 |
| 1990-1994 | 168 | 19 | 11.3 | 58 | 34.5 | 60 | 35.7 | 8 | 4.8 | 23 | 13.7 |
| 1989-1993 | 165 | 23 | 13.9 | 45 | 27.3 | 58 | 35.2 | 9 | 5.5 | 30 | 18.2 |
| 1988-1992 | 176 | 22 | 12.5 | 48 | 27.3 | 59 | 33.5 | 12 | 6.8 | 35 | 19.9 |
| 1987-1991 | 172 | 17 | 9.9 | 54 | 31.4 | 53 | 30.8 | 13 | 7.6 | 35 | 20.3 |
| 1986-1990 | 169 | 17 | 10.1 | 57 | 33.7 | 51 | 30.2 | 13 | 7.7 | 31 | 18.3 |
| 1985-1989 | 143 | 12 | 8.4 | 57 | 39.9 | 37 | 25.9 | 13 | 9.1 | 24 | 16.8 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |